Itamar Raz
Brigham and Women's Hospital
2 papers in the Anchorcite directory, published between 2001 and 2018, cited 12,605 times in total.
ORCID profileResearch topics
- Chronic Kidney Disease and Diabetes · 2 papers
- Diabetes Treatment and Management · 1 paper
- Heart Failure Treatment and Management · 1 paper
- Renin-Angiotensin System Studies · 1 paper
- Blood Pressure and Hypertension Studies · 1 paper
Frequent co-authors
- Stephen D. Wiviott · 1 paper
- Marc P. Bonaca · 1 paper
- Ofri Mosenzon · 1 paper
- Eri Toda Kato · 1 paper
- Avivit Cahn · 1 paper
- Michael G. Silverman · 1 paper
- Thomas A. Zelniker · 1 paper
- Julia Kuder · 1 paper
Papers
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine · 2018 · 6,600 citations
BACKGROUND: The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is undefined. METHODS: of body-surface area, new end-stage renal disease, or death from renal or cardiovascular causes)…
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine · 2001 · 6,005 citations
BACKGROUND: It is unknown whether either the angiotensin-II-receptor blocker irbesartan or the calcium-channel blocker amlodipine slows the progression of nephropathy in patients with type 2 diabetes independently of its capacity to lower the systemic blood pressure. METHODS: We randomly assigned…
Metadata from OpenAlex (CC0).